Cargando…
An assessment of the strategy and status of COVID-19 vaccination in India
The COVID-19 disease continues to cause devastation for almost 3 years of its identification. India is one of the leading countries to set clinical trials, production, and administration of COVID-19 vaccination. Recent COVID-19 vaccine tracker record suggests that 12 vaccines are approved in India,...
Autores principales: | Gupta, Sneh Lata, Goswami, Surbhi, Anand, Ananya, Naman, Namrata, Kumari, Priya, Sharma, Priyanka, Jaiswal, Rishi K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089693/ https://www.ncbi.nlm.nih.gov/pubmed/37041424 http://dx.doi.org/10.1007/s12026-023-09373-5 |
Ejemplares similares
-
An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
por: Gupta, Sneh Lata, et al.
Publicado: (2022) -
Neutralizing antibody: a savior in the Covid-19 disease
por: Gupta, Sneh Lata, et al.
Publicado: (2022) -
Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022) -
Children’s SARS-CoV-2 Infection and Their Vaccination
por: Gupta, Sneh Lata, et al.
Publicado: (2023) -
Immunotherapy: an alternative promising therapeutic approach against cancers
por: Gupta, Sneh Lata, et al.
Publicado: (2022)